CHROMATHERAPY Trademark

Trademark Overview


On Wednesday, February 14, 2024, a trademark application was filed for CHROMATHERAPY with the United States Patent and Trademark Office. The USPTO has given the CHROMATHERAPY trademark a serial number of 98405191. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 9, 2024. The CHROMATHERAPY trademark is filed in the Advertising, Business and Retail Services category with the following description:

Chromatherapy creates high end photo and video content for luxury brands to be used in social media, website design, and advertisements.
chromatherapy

General Information


Serial Number98405191
Word MarkCHROMATHERAPY
Filing DateWednesday, February 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChromatherapy creates high end photo and video content for luxury brands to be used in social media, website design, and advertisements.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 14, 2024
Primary Code035
First Use Anywhere DateWednesday, September 1, 2021
First Use In Commerce DateWednesday, September 1, 2021

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2024NEW APPLICATION ENTERED
Sunday, June 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 6, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Monday, September 9, 2024NON-FINAL ACTION E-MAILED